department of medical oncology;
guy’s and st thomas nhs trust;
London SE1 9RT;
United Kingdom;
division of cancer studies;
king’s college london;
guy’s hospital;
London SE1 9RT;
United Kingdom;
institute of liver studies;
king’s college hospital nhs trust;
London SE5 9RS;
United Kingdom;
Hepatocellular; carcinoma; Molecular; targets; Genomics; Sorafenib; Tyrosine; kinase; inhibitors;